Skip to main content
Clinical Trials/NCT06989385
NCT06989385RecruitingNot Applicable

CORALINE - Correlation Between Physiological and Clinical Variables and Failure of Non-Invasive Respiratory Support in Patients With Acute Respiratory Failure

University of Modena and Reggio Emilia0 sites325 target enrollmentStarted: November 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
325
Primary Endpoint
Rate of failure of non-invasive respiratory support

Study Overview

Brief Summary

This observational study aims to evaluate the relationship between clinical and physiological variables and the failure of non-invasive respiratory support (NIRS), including high-flow nasal oxygen (HFNO) and non-invasive ventilation (NIV), in patients with acute respiratory failure (ARF), both hypoxemic and/or hypercapnic. The study includes both retrospective and prospective components. Retrospective data will be collected from patient charts, while prospective data will be collected at defined time points during clinical care. The primary outcome is NIRS failure, defined as the need for orotracheal intubation. Secondary outcomes include in-hospital and 90-day mortality, ICU and hospital length of stay, and duration of non-invasive and invasive support.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥ 18 years
  • •Hospitalization in the Respiratory Medicine Unit at AOU Policlinico di Modena
  • •Acute respiratory failure (hypoxemic and/or hypercapnic) with PaO₂/FiO₂ < 300 mmHg
  • •Undergoing treatment with HFNO or NIV

Exclusion Criteria

  • •Immediate need for invasive ventilation upon admission
  • •Known neuromuscular disease
  • •Pregnancy
  • •Lack of informed consent

Outcomes

Primary Outcomes

Rate of failure of non-invasive respiratory support

Time Frame: 30 days

Number of patients experiencing NIRS failure (defined as escalation to another NIRS modality, need for orotracheal intubation, or death) over the total number of patients.

Secondary Outcomes

  • Clinical impact(From enrollment to 90 days)

Investigators

Sponsor
University of Modena and Reggio Emilia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Roberto Tonelli

Assistant Professor

University of Modena and Reggio Emilia

Similar Trials